remedē® System for Severe Sleep Apnea

Janus II Feasibility

Recruiting N/A Interventional Study
Sleep Apnea
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
Zoll Medical Corporation · Industry
Who this trial is looking for

This trial is looking for people with severe sleep apnea to test a device called the remedē® Dual Channel System. Participants will have the device implanted and undergo overnight sleep studies to see how well it works and to check for safety over time.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have severe sleep disordered breathing
  • I am expected to tolerate study procedures
  • I do not have heart failure or I have medically stable heart failure

You may not be able to join if

  • I currently have a neurostimulator for sleep apnea without approval
  • I have a history of severe COPD or pulmonary arterial hypertension
  • I have had nerve injury or palsy
  • I have had cervical surgeries or radiation to my head
  • I need an MRI
  • I have a history of psychosis or severe bipolar disorder
  • I have an active infection or sepsis within the last 30 days
  • I am currently on kidney dialysis or have reduced kidney function

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The objectives of this study are to evaluate the feasibility of the remedē® Dual Channel System at implant and overnight sleep studies and to assess chronic safety.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Severe sleep disordered breathing * Expected to tolerate study procedures * No heart failure or medically stable heart failure Exclusion Criteria: * Currently implanted with a neurostimulator to treat sleep disordered breathing without sponsor approval * History of severe CO…
Contacts

Samuel Kolapo

205-441-9519

samuel.kolapo@zoll.com

CONTACT

Janus II Study

JNS02@zoll.com

CONTACT